AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20586923 — intervention group
Group type: COMPARATOR
Intervention: Abciximab bolus + a 12-h infusion and 300 mg of clopidogrel
Number of subjects: 73
Study 17368341 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral compaction technique
Number of subjects: 36
Study 17368341 — intervention group
Group type: COMPARATOR
Intervention: Single-cone technique
Number of subjects: 36
Study 17368341 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal type (mandibular distal canal)
Number of subjects: 36
Study 17368341 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal type (mandibular mesial canal)
Number of subjects: 36
Study 17368341 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal type (maxillary palatal canals)
Number of subjects: 36
Study 15726575 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTXA) injection with low-frequency electrical nerve stimulation (NS) at 4 Hz
Number of subjects: 0
Study 15726575 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTXA) injection with high-frequency electrical nerve stimulation (NS) at 25 Hz
Number of subjects: 0
Study 15726575 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin type A (BTXA) injection without electrical nerve stimulation (NS)
Number of subjects: 0
Study 11927114 — intervention group
Group type: EXPERIMENTAL
Intervention: Full dose of Yuzpe regimen
Number of subjects: 60
Study 11927114 — intervention group
Group type: EXPERIMENTAL
Intervention: Half dose of Yuzpe regimen
Number of subjects: 60
Study 11927114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11927114 — intervention group
Group type: EXPERIMENTAL
Intervention: Yuzpe regimen (both doses)
Number of subjects: 60
Study 9862249 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg intravenous bolus)
Number of subjects: 15
Study 9862249 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with impaired adrenal function reserve
Number of subjects: 15
Study 9862249 — intervention group
Group type: COMPARATOR
Intervention: Septic patients
Number of subjects: 15
Study 9862249 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers (control group)
Number of subjects: 15
Study 7614641 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 20
Study 7614641 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 20
Study 2651178 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release salbutamol tablets (8 mg twice daily)
Number of subjects: 32
Study 2651178 — intervention group
Group type: COMPARATOR
Intervention: Sustained release theophylline preparation (400-800 mg given once each night)
Number of subjects: 32
Study 154872 — intervention group
Group type: COMPARATOR
Intervention: oral antibiotic + topical placebo lotion
Number of subjects: 45
Study 154872 — intervention group
Group type: EXPERIMENTAL
Intervention: oral antibiotic + topical ethyl lactate lotion
Number of subjects: 45
Study 154872 — intervention group
Group type: COMPARATOR
Intervention: topical ethyl lactate lotion only
Number of subjects: 45
Study 31298169 — intervention group
Group type: EXPERIMENTAL
Intervention: START intervention (an eight-session manual-based coping intervention delivered by supervised psychology graduates)
Number of subjects: 260
Study 31298169 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 260
Study 31298169 — intervention group
Group type: EXPERIMENTAL
Intervention: START intervention
Number of subjects: 260
Study 30722036 — intervention group
Group type: EXPERIMENTAL
Intervention: GroupCoreDIST intervention
Number of subjects: 80
Study 30722036 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 28598910 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 12
Study 28598910 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 12
Study 25441065 — intervention group
Group type: EXPERIMENTAL
Intervention: MIS-RDAVR (Minimally Invasive Rapid Deployment Aortic Valve Replacement)
Number of subjects: 94
Study 25441065 — intervention group
Group type: COMPARATOR
Intervention: FS-AVR (Conventional Full Sternotomy Aortic Valve Replacement)
Number of subjects: 94
Study 23147203 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions
Number of subjects: 847
Study 23147203 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual interventions
Number of subjects: 847
Study 23147203 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 847
Study 20923909 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) with a 25% reduction of ad libitum energy intake over 2 years
Number of subjects: 225
Study 20923909 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 225
Study 20923909 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 225
Study 19433757 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie-expenditure exercise (3000-3500 kcal/wk)
Number of subjects: 74
Study 19433757 — intervention group
Group type: COMPARATOR
Intervention: Standard CR exercise (700-800 kcal/wk)
Number of subjects: 74
Study 16684121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg)
Number of subjects: 8
Study 16684121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 16684121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 8
Study 14651947 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress (Stroop test)
Number of subjects: 50
Study 14651947 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation (tape)
Number of subjects: 50
Study 14651947 — intervention group
Group type: COMPARATOR
Intervention: Control (video)
Number of subjects: 50
Study 14651947 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin injection
Number of subjects: 50
Study 11703863 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Blood (WB)
Number of subjects: 60
Study 11703863 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffy Coat-Poor Packed Red Cells and Fresh-Frozen Plasma (RCP)
Number of subjects: 60
Study 11703863 — intervention group
Group type: COMPARATOR
Intervention: Non-Transfused (NT)
Number of subjects: 60
Study 9237055 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 193
Study 9237055 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 193
Study 7488359 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Winterfresh Gel with 0.76% sodium monofluorophosphate (MFP)
Number of subjects: 2222
Study 7488359 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Regular Flavor Toothpaste with 0.24% sodium fluoride (NaF)
Number of subjects: 2222
Study 7488359 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Junior Toothpaste with 0.243% sodium fluoride (NaF)
Number of subjects: 2222
Study 3328680 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine 1.0 microgram kg‐1 min‐1 (Group 1, n = 15)
Number of subjects: 45
Study 3328680 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 0.70 microgram kg‐1 min‐1 (Group 2, n = 15)
Number of subjects: 45
Study 3328680 — intervention group
Group type: COMPARATOR
Intervention: No calcium channel blocker (Group 3, n = 15)
Number of subjects: 45
Study 29525970 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping oral bisphosphonate treatment (ibandronate, alendronate, risedronate)
Number of subjects: 0
Study 26073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin (DS-5565)
Number of subjects: 0
Study 26073181 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin (150 mg, dosed twice daily)
Number of subjects: 0
Study 26073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin (17.7 mg estimated dose)
Number of subjects: 0
Study 26073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin (twice-daily dosing)
Number of subjects: 0
Study 26073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirogabalin
Number of subjects: 0
Study 25555537 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood vodcast
Number of subjects: 42
Study 25555537 — intervention group
Group type: COMPARATOR
Intervention: Control condition (blue static background, neutral music, and script describing objective facts)
Number of subjects: 42
Study 23607837 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunophenotyping and protein profiling of airway casts
Number of subjects: 0
Study 20622383 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg/day of Fungisome
Number of subjects: 10
Study 20622383 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg/day of Fungisome
Number of subjects: 10
Study 18705811 — intervention group
Group type: EXPERIMENTAL
Intervention: BCP (biphasic calcium phosphate)
Number of subjects: 37
Study 18705811 — intervention group
Group type: COMPARATOR
Intervention: ABB (anorganic bovine bone)
Number of subjects: 37
Study 17078006 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination probiotics and nutrients
Number of subjects: 72
Study 17078006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 15579984 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpupillary frequency‐doubled Nd:YAG laser retinopexy
Number of subjects: 703
Study 15579984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for retinopexy
Number of subjects: 703
Study 11369844 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention with epoetin beta (Hb level 11‐12.5 g/dl, target Hb 13‐15 g/dl)
Number of subjects: 600
Study 11369844 — intervention group
Group type: COMPARATOR
Intervention: Late intervention with epoetin beta (Hb level <10.5 g/dl, target Hb 10.5‐11.5 g/dl)
Number of subjects: 600
Study 9416886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitostanol ester margarine (3 g/d) for 7 weeks
Number of subjects: 32
Study 9416886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitostanol ester margarine combined with simvastatin for 12 weeks
Number of subjects: 32
Study 9416886 — intervention group
Group type: COMPARATOR
Intervention: Home diet (control)
Number of subjects: 32
Study 8512911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) applied to one side of the mouth after surgery
Number of subjects: 64
Study 8512911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-operating model) applied to the other side of the mouth after surgery
Number of subjects: 64
Study 8512911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 64
Study 8512911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-operating model)
Number of subjects: 64
Study 2979215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous famotidine at 10 ng ml-1
Number of subjects: 8
Study 2979215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous famotidine at 30 ng ml-1
Number of subjects: 8
Study 2979215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous famotidine at 90 ng ml-1
Number of subjects: 8
Study 2979215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin 0.1 micrograms kg-1.hour with famotidine at 4.3 micrograms kg-1.hour
Number of subjects: 8
Study 2979215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin 2.0 micrograms kg-1.hour with famotidine at 4.3 micrograms kg-1.hour
Number of subjects: 8
Study 2979215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31355957 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored self-management resources
Number of subjects: 214
Study 31355957 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 214
Study 29565636 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual Care + Homeopathy Treatment (UC + HT)
Number of subjects: 60
Study 29565636 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60
Study 26693800 — intervention group
Group type: EXPERIMENTAL
Intervention: DHAP (dexamethasone, high-dose cytarabine, cisplatin)
Number of subjects: 266
Study 24527578 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine treatment
Number of subjects: 225
Study 24527578 — intervention group
Group type: COMPARATOR
Intervention: Regular Western and Chinese medicine treatments
Number of subjects: 225
Study 22182482 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet low-ratio (LR) - n-6:n-3 = 1.7:1
Number of subjects: 11
Study 22182482 — intervention group
Group type: COMPARATOR
Intervention: Diet high-ratio (HR) - n-6:n-3 = 30:1
Number of subjects: 11
Study 19933991 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Care Protocol (DCP)
Number of subjects: 0
Study 19933991 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 18929505 — intervention group
Group type: COMPARATOR
Intervention: 3 months of maximum short-term androgen deprivation (STAD) before and during radiation
Number of subjects: 802
Study 18929505 — intervention group
Group type: COMPARATOR
Intervention: 6 months of maximum short-term androgen deprivation (STAD) before and during radiation
Number of subjects: 802
Study 18929505 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to biochemical failure (TTBF)
Number of subjects: 802
Study 18929505 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen doubling time (PSADT)
Number of subjects: 802
Study 15765242 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnasts
Number of subjects: 20
Study 15765242 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 20
Study 11982446 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram medication
Number of subjects: 18
Study 11982446 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy
Number of subjects: 18
Study 11982446 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 18
Study 11982446 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treated groups (Citalopram and Cognitive-behavioral therapy)
Number of subjects: 18
Study 11982446 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders (regardless of treatment approach)
Number of subjects: 18
Study 9789193 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 18
Study 9789193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8552510 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous aspirin (0.015 g/kg body weight)
Number of subjects: 42
Study 8552510 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 42
Study 2199589 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 36
Study 2199589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 995333 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduction scoring systems (five systems evaluated)
Number of subjects: 0
Study 995333 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduction score modifiers
Number of subjects: 0
Study 31394106 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized advice (PA)
Number of subjects: 59
Study 31394106 — intervention group
Group type: COMPARATOR
Intervention: Generic advice (GA)
Number of subjects: 59
Study 31394106 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PA and GA
Number of subjects: 59
Study 27913260 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG) test
Number of subjects: 109
Study 27913260 — intervention group
Group type: COMPARATOR
Intervention: Patient-Reported Outcome Measures (PROMs)
Number of subjects: 109
Study 26123142 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 2.5mg
Number of subjects: 180
Study 26123142 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8mg
Number of subjects: 180
Study 26123142 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 10mg (Control)
Number of subjects: 180
Study 26591709 — intervention group
Group type: EXPERIMENTAL
Intervention: Fistulectomy (Group A)
Number of subjects: 162
Study 26591709 — intervention group
Group type: COMPARATOR
Intervention: Fistulotomy with marsupialisation (Group B)
Number of subjects: 162
Study 21779973 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium (3.6 g × 2/day) during rehabilitation
Number of subjects: 45
Study 21779973 — intervention group
Group type: COMPARATOR
Intervention: High-fiber diet (approximately 30 g fiber per day) during rehabilitation
Number of subjects: 45
Study 20051465 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandometer (computerised device providing real time feedback during meals)
Number of subjects: 106
Study 20051465 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandometer
Number of subjects: 106
Study 20051465 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 106
Study 17848908 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual patient information (AVPI)
Number of subjects: 173
Study 17848908 — intervention group
Group type: COMPARATOR
Intervention: Standard written information
Number of subjects: 173
Study 15313811 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser treatment
Number of subjects: 31
Study 15313811 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated lesions)
Number of subjects: 31
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethizole
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim + Sulfamethizole
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecillinam
Number of subjects: 69
Study 11571862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 69
Study 9758264 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg)‐containing multivitamin supplementation
Number of subjects: 60
Study 9758264 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg)‐containing multivitamin
Number of subjects: 60
Study 9758264 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological dose (<1 mg) of folic acid
Number of subjects: 60
Study 9758264 — intervention group
Group type: EXPERIMENTAL
Intervention: Another multivitamin (not specified)
Number of subjects: 60
Study 7921862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (10 micrograms)
Number of subjects: 156
Study 7921862 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 156
Study 7921862 — intervention group
Group type: COMPARATOR
Intervention: Control group (no opioids)
Number of subjects: 156
Study 7921862 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 156
Study 2970360 — intervention group
Group type: EXPERIMENTAL
Intervention: Human atrial natriuretic peptide (alpha-hANP; 100 micrograms)
Number of subjects: 8
Study 2970360 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study 4359162 — intervention group
Group type: EXPERIMENTAL
Intervention: l(‐) amphetamine
Number of subjects: 12
Study 4359162 — intervention group
Group type: EXPERIMENTAL
Intervention: d(+) amphetamine
Number of subjects: 12
Study 4359162 — intervention group
Group type: EXPERIMENTAL
Intervention: clomipramine with either amphetamine
Number of subjects: 12
Study 4359162 — intervention group
Group type: COMPARATOR
Intervention: l(‐) amphetamine and d(+) amphetamine
Number of subjects: 12
Study 31943197 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (10 to 50 mg daily)
Number of subjects: 50
Study 31340634 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT), Group 1, n = 37
Number of subjects: 74
Study 31340634 — intervention group
Group type: COMPARATOR
Intervention: Sham taping, Group 2, n = 37
Number of subjects: 74
Study 28148255 — intervention group
Group type: EXPERIMENTAL
Intervention: TASSH training
Number of subjects: 64
Study 25687111 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-focused coping strategies
Number of subjects: 125
Study 25687111 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher socioeconomic status
Number of subjects: 125
Study 25687111 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender of the adolescent
Number of subjects: 125
Study 25687111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer children in the home
Number of subjects: 125
Study 25687111 — intervention group
Group type: COMPARATOR
Intervention: Adolescent TBI severity
Number of subjects: 125
Study 25687111 — intervention group
Group type: COMPARATOR
Intervention: Caregiver depression
Number of subjects: 125
Study 24040767 — intervention group
Group type: EXPERIMENTAL
Intervention: Retransfusion of unwashed cardiotomy suction blood (mean volume 280 ml, corresponding to 5% of blood volume)
Number of subjects: 30
Study 24040767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex vivo addition of 10% and 20% suction blood to systemic blood
Number of subjects: 30
Study 24040767 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotomy suction blood
Number of subjects: 30
Study 24040767 — intervention group
Group type: COMPARATOR
Intervention: Systemic blood
Number of subjects: 30
Study 21406278 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-university partnership model
Number of subjects: 11960
Study 21406278 — intervention group
Group type: COMPARATOR
Intervention: Usual-programming conditions
Number of subjects: 11960
Study 19522261 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative epidural buprenorphine 0.2 mg
Number of subjects: 28
Study 19522261 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (control group)
Number of subjects: 28
Study 17087192 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-based 13C-urea breath test (13C-UBT)
Number of subjects: 0
Study 15530758 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention
Number of subjects: 0